A new dedicated service for CAR T-cell therapy is set to launch, aimed at improving treatment options for patients with blood cancers. This innovative...
A new dedicated CAR T-cell therapy service will be established to enhance treatment options for patients suffering from blood cancers. This innovative therapy, which...
Researchers at Karolinska Institutet have uncovered a significant vulnerability in certain blood cancer cells, potentially leading to targeted treatment options for myelodysplastic syndrome (MDS)....